These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32255021)

  • 1. Nanomized tumor-microenvironment-active NIR fluorescent prodrug for ensuring synchronous occurrences of drug release and fluorescence tracing.
    Li Q; Cao J; Wang Q; Zhang J; Zhu S; Guo Z; Zhu WH
    J Mater Chem B; 2019 Mar; 7(9):1503-1509. PubMed ID: 32255021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug.
    Wu X; Sun X; Guo Z; Tang J; Shen Y; James TD; Tian H; Zhu W
    J Am Chem Soc; 2014 Mar; 136(9):3579-88. PubMed ID: 24524232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSH-Activated NIR Fluorescent Prodrug for Podophyllotoxin Delivery.
    Liu Y; Zhu S; Gu K; Guo Z; Huang X; Wang M; Amin HM; Zhu W; Shi P
    ACS Appl Mater Interfaces; 2017 Sep; 9(35):29496-29504. PubMed ID: 28758393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
    Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
    Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier-free Janus nano-prodrug based on camptothecin and gemcitabine: Reduction-triggered drug release and synergistic in vitro antiproliferative effect in multiple cancer cells.
    Xu Y; Huang Y; Zhang X; Lu W; Yu J; Liu S
    Int J Pharm; 2018 Oct; 550(1-2):45-56. PubMed ID: 30138703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-Initiated Synthesis of Heterotelechelic Polymer Prodrug Nanoparticles for in Vivo Imaging and Cancer Cell Targeting.
    Vinciguerra D; Degrassi A; Mancini L; Mura S; Mougin J; Couvreur P; Nicolas J
    Biomacromolecules; 2019 Jul; 20(7):2464-2476. PubMed ID: 31150219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
    Wang Z; Wu H; Liu P; Zeng F; Wu S
    Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereocomplex Prodrugs of Oligo(lactic acid)
    Tam YT; Huang C; Poellmann M; Kwon GS
    ACS Nano; 2018 Jul; 12(7):7406-7414. PubMed ID: 29957934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revealing the impact of modified modules flexibility on gemcitabine prodrug nanoassemblies for effective cancer therapy.
    Guo J; Zhang X; Dong F; Wang S; Wang D; Li Y; Zuo S; Wang Q; Li W; Sun J; He Z; Zhang T; Jiang Q; Sun B
    J Colloid Interface Sci; 2025 Jan; 677(Pt A):941-952. PubMed ID: 39128288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A biocompatible and cathepsin B sensitive nanoscale system of dendritic polyHPMA-gemcitabine prodrug enhances antitumor activity markedly.
    Dai Y; Ma X; Zhang Y; Chen K; Tang JZ; Gong Q; Luo K
    Biomater Sci; 2018 Nov; 6(11):2976-2986. PubMed ID: 30255871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced anti-tumor efficiency of gemcitabine prodrug by FAPα-mediated activation.
    Sun J; Yang D; Cui SH; Zhang HT; Fu Y; Wang JC; Zhang Q
    Int J Pharm; 2019 Mar; 559():48-57. PubMed ID: 30677483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymer prodrug nanoparticles based on naturally occurring isoprenoid for anticancer therapy.
    Trung Bui D; Maksimenko A; Desmaële D; Harrisson S; Vauthier C; Couvreur P; Nicolas J
    Biomacromolecules; 2013 Aug; 14(8):2837-47. PubMed ID: 23829862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44-targeting hydrophobic phosphorylated gemcitabine prodrug nanotherapeutics augment lung cancer therapy.
    Guo B; Wei J; Wang J; Sun Y; Yuan J; Zhong Z; Meng F
    Acta Biomater; 2022 Jun; 145():200-209. PubMed ID: 35430336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-assembled multifunctional nanotheranostics loading GEM for targeted lung cancer therapy.
    Tang J; Zheng F; Zhao J; Zhao J
    Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110786. PubMed ID: 32409023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-Delivery Nanoparticles of Amphiphilic Methotrexate-Gemcitabine Prodrug for Synergistic Combination Chemotherapy via Effect of Deoxyribonucleotide Pools.
    Wang Y; Huang P; Hu M; Huang W; Zhu X; Yan D
    Bioconjug Chem; 2016 Nov; 27(11):2722-2733. PubMed ID: 27723981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Glutathione (GSH)-Responsive Near-Infrared (NIR) Theranostic Prodrug for Cancer Therapy and Imaging.
    Kong F; Liang Z; Luan D; Liu X; Xu K; Tang B
    Anal Chem; 2016 Jun; 88(12):6450-6. PubMed ID: 27216623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomimetic nanoassemblies of 1-O-octodecyl-2-conjugated linoleoyl-sn-glycero-3-phosphatidyl gemcitabine with phospholipase A
    Zuo J; Tong L; Du L; Yang M; Jin Y
    Colloids Surf B Biointerfaces; 2017 Apr; 152():467-474. PubMed ID: 28187380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
    Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
    Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyamine-Targeting Gefitinib Prodrug and its Near-Infrared Fluorescent Theranostic Derivative for Monitoring Drug Delivery and Lung Cancer Therapy.
    Song X; Han X; Yu F; Zhang X; Chen L; Lv C
    Theranostics; 2018; 8(8):2217-2228. PubMed ID: 29721074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermosensitive polymer prodrug nanoparticles prepared by an all-aqueous nanoprecipitation process and application to combination therapy.
    Guerassimoff L; Ferrere M; Van Herck S; Dehissi S; Nicolas V; De Geest BG; Nicolas J
    J Control Release; 2024 May; 369():376-393. PubMed ID: 38554772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.